Back to results
US 2026/0227400 A1Published application
SARS-CoV-2 DETECTION METHOD AND KIT THEREFOR
AssigneeDenka Company Limited
InventorsToru YAMAGUCHI, Daisuke KATO, Shino MURAMATSU
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeDenka Company Limited
InventorsToru YAMAGUCHI, Daisuke KATO, Shino MURAMATSU
Estimating the term…
Disclosed is a high performance anti-SARS-CoV-2 antibody and a detection reagent using it. The method of detecting SARS-CoV-2 includes detecting SARS-CoV-2 in a sample by an immunoassay method using a monoclonal antibody that specifically reacts with 301aa-319aa, 301aa-320aa, or 351aa-375aa of the amino acid sequence of the N protein of SARS-CoV-2, or an antigen-binding fragment thereof. The detection kit for SARS-CoV-2 includes a monoclonal antibody that specifically reacts with 301aa-319aa, 301aa-320aa, or 351aa-375aa of the amino acid sequence of the N protein of SARS-CoV-2, or an antigen-binding fragment thereof.
A method of detecting SARS-CoV-2, comprising detecting SARS-CoV-2 in a sample by an immunoassay method using a monoclonal antibody that specifically reacts with 301aa-319aa, 301aa-320aa, or 351aa-375aa of the amino acid sequence of the N protein of SARS-CoV-2, or an antigen-binding fragment thereof.
A detection kit for SARS-CoV-2, comprising a monoclonal antibody that specifically reacts with 301aa-319aa, 301aa-320aa, or 351aa-375aa of the N protein of SARS-CoV-2, or an antigen-binding fragment thereof.
Dependencies are inferred from the claim text.